Halo Neuroscience Receives $1,500,000 New Funding Round

  • Feed Type
  • Date
    5/1/2014
  • Company Name
    Halo Neuroscience
  • Mailing Address
    33 W. 17th Street 4th Floor New York, NY 10011 USA
  • Company Description
    Neuromodulation technology that elevates cognitive performance. Halo is developing a novel, simple, and powerful neuroscience-based technology for enhancing performance on cognitive tasks, for the healthy and impaired.
  • Website
    http://www.haloneuro.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    They will primarily work on IP and safety issues with the Food and Drug Administration to ensure that the product doesn’t make us all hallucinate.
  • M&A Terms
  • Venture Investor
  • Venture Investor